Based on the abovementioned findings, we speculated that PAR-1 activation might initiate PI3K/Akt signaling and phosphorylate downstream MAPK and NF-κB targets, thereby amplifying the inflammatory response in lung IR injury. The gene discussed is F2R; the disease is medical procedure.